Sep 10, 2026 02:20PM
Jun 4, 2026 05:39PM
Dec 8, 2025 04:13PM
Jul 2, 2025 08:00AM
Jun 28, 2025 11:00AM
May 27, 2025 02:00AM
Apr 17, 2025 01:11PM Hikma (HKMPY) acquires Novugen's ANDA for trametinib
Apr 17, 2025 01:10PM
Mar 20, 2025 08:06AM
Jan 14, 2025 07:41AM
Aug 20, 2024 12:15PM
Aug 15, 2024 03:18PM
Feb 21, 2024 01:20PM
Feb 5, 2024 07:00AM Hikma announces US launch of COMBOGESIC® IV
Oct 3, 2023 07:00AM
Jun 15, 2023 03:00PM
Dec 26, 2022 03:06AM
Aug 30, 2022 07:12AM
Apr 21, 2022 09:28AM
Mar 22, 2022 09:00AM
Jan 10, 2022 02:00AM Hikma Launches New 503B Sterile Compounding Business
Oct 22, 2021 08:00AM
Sep 27, 2021 05:42AM
Sep 27, 2021 02:00AM
Sep 20, 2021 01:30PM
Aug 4, 2021 08:00AM
Apr 30, 2021 02:00AM
Apr 28, 2021 02:15PM Hikma announces exclusive agreement with AFT Pharmaceuticals for injectable non-opioid pain medication Combogesic® IV in the US
Apr 20, 2021 04:00PM
Dec 17, 2020 04:30PM
Dec 1, 2020 08:02AM
Dec 1, 2020 08:00AM
Oct 20, 2020 03:00AM
Oct 20, 2020 03:00AM
Sep 3, 2020 10:45AM Hikma receives favourable court ruling for its generic Vascepa®
May 28, 2020 03:00AM
May 22, 2020 02:00AM
May 12, 2020 03:00AM
May 4, 2020 08:00AM
May 4, 2020 08:00AM
Mar 31, 2020 02:00AM
Feb 27, 2020 02:01AM Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US
Jan 9, 2020 03:00AM
Jan 9, 2020 03:00AM
Dec 10, 2019 07:04AM
Sep 17, 2019 04:00AM
Jul 23, 2019 07:00AM
May 1, 2019 05:56PM
Nov 30, 2018 05:36PM Hikma Demonstrates Support for US Pharmacists and Patient Safety
Jul 18, 2018 07:00AM

332,331 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All